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Susumu Mitsutake
Winner of the 2013
Young Group Leader AwardOnce again the FEBS Letters Young Group Leader Award reaches
the Far East. Susumu Mitsutake, Associate Professor in Biomem-
brane and Biofunctional Chemistry at the Faculty of Advanced Life
Sciences, University of Hokkaido, Japan, was granted the presti-
gious FEBS Letters award for his outstanding article ‘‘Ceramide ki-
nase deﬁciency improves diet-induced obesity and insulin
resistance’’ [1] published in FEBS Letters in 2012. The award-win-
ning paper is a comprehensive study on the effect of ceramide ki-
nase (CERK) deﬁciency on obesity and obesity-induced insulin
resistance in vivo with a focus on the role of CERK signaling in
macrophages.
What is the main message of your award winning paper?
Obesity is often associated with chronic low-grade inﬂamma-
tion that leads to insulin resistance and the development of diabe-
tes. Adipocytes secrete the chemokine MCP1 (monocyte
chemoattractant protein 1), which signals to macrophages via the
C-C motif chemokine receptor 2 (CCR2) and mediates macrophage
inﬁltration in the adipose tissue. Using a knock out mouse model,
we found that CERK deﬁciency renders mice impervious to high fat
diet-induced obesity and diabetes. In contrast to the adipose tissue
of wild type mice on the same diet, CERK/ adipocytes remained
small and did not secrete MCP1, they did not express inﬂammatory
markers and they had increased levels of GLUT4 and insulin recep-
tor (IR). CERK deﬁcient macrophages expressed normal levels of
CCR2, but were unable to transmit the signal further downstream.
As a result, these macrophages did not inﬁltrate the adipose tissue
or form the typical ‘‘crown-like structures’’ around dead adipo-
cytes. So CERK deﬁciency seems to act on two fronts in our model:
on the adipocytes preventing obesity, and on the macrophages pre-
venting the inﬂammatory response. The combination of these
events protects the animals from developing diabetes.How does CERK regulate the MCP1 signaling pathway?
This point is still under investigation. We previously showed
that CERK mediates the transbilayer movement of ceramide in
the plasma membrane [2]. We suspect that CERK deﬁciency in
macrophages somehow affects the biophysical properties of the
plasma membrane thereby impairing CCR2 signaling.http://dx.doi.org/10.1016/j.febslet.2013.05.001On the other hand, in adipocytes CERK is involved in the biogenesis
of lipiddroplets [3], and I doubt it is directly involved in the secretionof
MCP1.Macrophage inﬁltration in the adipose tissue, and the formation
of crown like structures, are necessary to stimulate MCP1 secretion in
adipocytes. Therefore, a diminished inﬁltration of macrophages leads
to lower MCP1 expression levels in adipocytes.
What therapeutic applications could these ﬁndings lead to?
Our study points to CERK inhibitors as potentially good candi-
dates as drugs against metabolic disease. Actually, we recently
showed that sphingomyelin synthase 2 (SMS2) is also involved in
diet-induced obesity [4]. This suggests that all enzymes involved
in ceramide metabolism could potentially be good targets for ther-
apy against obesity and diabetes.
Are you actually working in this direction?
A speciﬁc inhibitor for CERK has already been developed [5], so
we are focusing on the SMS2 inhibitor. We have already patented a
screening method for discriminating between SMS1 and SMS2,
which we expect to be helpful for identifying an SMS2-speciﬁc
inhibitor.
What do you like about being a scientist, and what is the
downside?
As a student, I was fascinated by Singer and Nicolson’s Fluid
Mosaic Model of the plasma membrane, and later inspired by
Sen-Ichiro Hakomori and Kai Simon’s lipid microdomain or lipid
raft model. That is what made me want to study lipid biochemistry,
and especially sphingolipids. What I ﬁnd most motivating about
being a scientist is the chance to discover important processes of
living organisms. The only drawback of this profession is that re-
search requires a lot of money, and much of a scientist’s time is
spent on writing grants and ﬁnding funds.
Were you aware of the Young Group Leader Award when you
submitted your study to FEBS Letters?
Yes, I knew about the prize because there are several Japanese
among the past winners, some of which are famous young leaders
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could win the prize. I feel very lucky and honored that so many
people around the world will read and evaluate my work. I think
that the award is a great opportunity for young group leaders.
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